Dianthus Therapeutics DNTH Total debt

Total debt at other companies

Johnson & JohnsonJNJ

$49.04B-3.4%

AmgenAMGN

$57.3B+2.0%

AnaptysBio, Inc.ANAB

$13.61K-99.9%

Vor BiopharmaVOR

$2.94M-90.5%

Cullinan Therapeutics, Inc.CGEM

$2.07M+36.3%

Shattuck Labs, Inc.STTK

$2.89M-9.5%

FAQ

What is Dianthus Therapeutics's total debt?

Dianthus Therapeutics (DNTH) reported total debt of $1.36M in Q1 2026.

How has Dianthus Therapeutics's total debt changed year-over-year?

Dianthus Therapeutics's total debt decreased by 2.3% year-over-year, from $1.4M to $1.36M.

What is the long-term trend for Dianthus Therapeutics's total debt?

Over 3 years (2022 to 2025), Dianthus Therapeutics's total debt has grown at a -64.1% compound annual growth rate (CAGR), from $29.96M to $1.39M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.